Showing 7231-7240 of 23138 results for "".
Are Practicing Ob-Gyn Oncologists on Your Speed Dial?
https://reachmd.com/programs/clinicians-roundtable/are-practicing-ob-gyn-oncologists-on-your-speed-dial/7902/What is the role and importance of the Ob-Gyn Oncologist, especially for women diagnosed with pelvic cancers? What are some barriers patients face in seeing an Ob-Gyn Oncoloogist? And how can clinicians better partner with this group of specialists? In this episode, host Dr. Renee Allen explores anRoles of the Pituitary Gland in Health and Disease: The Clinician's Workup Guide
https://reachmd.com/programs/primary-care-today/roles-pituitary-gland-health-disease-clinicians-workup-guide/7665/Dr. Brian McDonough welcomes Dr. Marcy Lake, faculty member of the Kaiser Permanente Family Medicine Residency Program in Portland Oregon and author of a recent article in American Family Physician devoted to disorders of the pituitary gland. Their discussion tours diagnostic considerations toward tFemale Sexual Dysfunction: Common Problem But Uncommonly Discussed
https://reachmd.com/programs/clinicians-roundtable/female-sexual-dysfunction-common-problem-but-uncommonly-discussed/7045/Female sexual dysfunction (FSD) occurs in about 20 - 60% of patients. FSD is common problem but how comfortable are clinicians in disussing this with their patients? Host Dr. Prathima Setty welcomes Dr. Draion "Dr. Drai" Burch, obstetrician-gynecologist and teaching faculty member at Magee-Womens HoHow Can Nurse Practitioners Reduce Stress on the Job? Tips from a Life Coach
https://reachmd.com/programs/partners-in-practice/how-can-nurse-practitioners-reduce-stress-on-the-job-tips-from-a-life-coach/6434/Nurse Practitioners often put their patients' health and well being before their own. A career as an NP can be stressful, overwhelming and the pressure of juggling work and home can make life feel like it is spinning out of control. Pratt Bennett owner of Make That Leap!, a Boston, Massachusetts lDESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/destiny-breast11-neoadjuvant-care-her2-positive-breast-cancer/39722/The DESTINY-Breast11 trial explored a neoadjuvant treatment approach for patients with high-risk, HER2-positive early-stage breast cancer. This phase III study compared standard chemotherapy with regimens incorporating T-DXd, aiming to optimize efficacy while potentially reducing toxicity. Hear Dr.Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
https://reachmd.com/programs/project-oncology/real-world-cases-in-pediatric-low-grade-glioma/37197/What’s guiding today’s treatment decisions for patients with pediatric low-grade glioma? Find out with Dr. Alexandria May as she speaks with Drs. Angela Waanders and Ashley Margol. Together, they examine real-world patient cases that highlight evolving approaches to care, including targeted therapieOptimizing Hair Transplant Outcomes with Medical Therapies
https://reachmd.com/programs/dermconsult/hair-transplant-outcomes-medical-therapies/49027/For patients undergoing hair transplants, adjunctive medical and regenerative therapies are essential for long-term success. Hear from Dr. Marc Avram as he reviews our current options and key considerations for patient care. Dr. Avram is a dermatologist, hair loss and transplant specialist, and ClinElderly Patients with IBD: Management Strategies and Care
https://reachmd.com/programs/gi-insights/elderly-patients-with-ibd-management-strategies-and-care/18101/What are some challenges that arise when diagnosing elderly patients with IBD? Find out here.The Updated Role of Non-Invasive Biomarkers in MASLD
https://reachmd.com/programs/gi-insights/the-updated-role-of-non-invasive-biomarkers-in-masld/15980/What is the role of non-invasive biomarkers in MASLD? Here’s the AGA’s clinical practice update.IBD and Biosimilars: What Healthcare Professionals Need to Know
https://reachmd.com/programs/gi-insights/ibd-and-biosimilars-what-healthcare-professionals-need-to-know/13835/Do you know how the approval of biosimilars will impact the treatment of inflammatory bowel disease? Hear from our experts and stay up to date!